GN Store Nord A/S
OTC:GGNDF

Watchlist Manager
GN Store Nord A/S Logo
GN Store Nord A/S
OTC:GGNDF
Watchlist
Price: 16.41 USD
Market Cap: $2.4B

P/S

0.8
Current
25%
Cheaper
vs 3-y average of 1.1

Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.

P/S
0.8
=
Market Cap
$13.3B
/
Revenue
kr16.8B

Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.

P/S
0.8
=
Market Cap
$13.3B
/
Revenue
kr16.8B

Valuation Scenarios

GN Store Nord A/S is trading below its 3-year average

If P/S returns to its 3-Year Average (1.1), the stock would be worth $21.86 (33% upside from current price).

Statistics
Positive Scenarios
4/4
Maximum Downside
No Downside Scenarios
Maximum Upside
+216%
Average Upside
110%
Scenario P/S Value Implied Price Upside/Downside
Current Multiple 0.8 $16.41
0%
3-Year Average 1.1 $21.86
+33%
5-Year Average 1.3 $25.89
+58%
Industry Average 2.6 $51.9
+216%
Country Average 1.9 $38.09
+132%

Forward P/S
Today’s price vs future revenue

Today's Market Cap Revenue Forward P/S
$13.3B
/
Jan 2026
kr16.8B
=
0.8
Current
$13.3B
/
Dec 2026
kr17.8B
=
0.7
Forward
$13.3B
/
Dec 2027
kr18.6B
=
0.7
Forward
$13.3B
/
Dec 2028
kr19.6B
=
0.7
Forward
$13.3B
/
Dec 2029
kr13.3B
=
1
Forward
$13.3B
/
Dec 2030
kr14.6B
=
0.9
Forward

Forward P/S shows whether today’s P/S still looks high or low once future revenue are taken into account.

Peer Comparison

All Multiples
P/S
P/E
All Countries
Close
Market Cap P/S P/E
DK
GN Store Nord A/S
OTC:GGNDF
14.1B USD 0.8 21.1
US
Intuitive Surgical Inc
NASDAQ:ISRG
161.2B USD 16.1 56.9
US
Abbott Laboratories
NYSE:ABT
158.6B USD 3.5 25.1
US
Stryker Corp
NYSE:SYK
120.5B USD 4.8 37.1
IE
Medtronic PLC
NYSE:MDT
101.9B USD 2.9 22.5
US
Boston Scientific Corp
NYSE:BSX
84.8B USD 4.1 24
US
Edwards Lifesciences Corp
NYSE:EW
47.2B USD 7.7 44.2
DE
Siemens Healthineers AG
XETRA:SHL
39.3B EUR 1.7 18.6
US
IDEXX Laboratories Inc
NASDAQ:IDXX
44.1B USD 10.4 42.2
US
Becton Dickinson and Co
NYSE:BDX
41.4B USD 1.9 24.2
US
Resmed Inc
NYSE:RMD
30.9B USD 5.8 21

Market Distribution

Lower than 99% of companies in Denmark
Percentile
1st
Based on 438 companies
1st percentile
0.1
Low
0.1 — 1.3
Typical Range
1.3 — 3.5
High
3.5 —
Distribution Statistics
Denmark
Min 0.1
30th Percentile 1.3
Median 1.9
70th Percentile 3.5
Max 37.5

GN Store Nord A/S
Glance View

Market Cap
2.4B USD
Industry
Health Care

In the bustling world of global technology, GN Store Nord A/S stands out as a fascinating player with a legacy dating back to 1869. Originally rooted in the telegraph industry, the company has adeptly metamorphosed through time to become a leader in hearing aids and audio devices. The heart of GN Store Nord's business beats in its dual prowess: GN Hearing and GN Audio. These twin pillars allow the company to seamlessly blend healthcare innovation with cutting-edge consumer technology. GN Hearing focuses on the development and production of advanced hearing aid solutions, catering to the growing demographic of individuals seeking quality life enhancements through better hearing. By leveraging sophisticated technologies, such as artificial intelligence and wireless connectivity, GN Hearing offers a range of products that improve the auditory experience for users worldwide. Parallelly, GN Audio operates under the brand Jabra, where it crafts a variety of audio and video solutions that cater to both professional and personal needs. From state-of-the-art headsets used in corporate environments to immersive earbuds favored by audiophiles, GN Audio has carved a significant niche for itself in the audio market. The synergy between GN's hearing and audio segments not only fuels revenue generation but also sustains its commitment to innovation, allowing the company to adapt and thrive in an ever-evolving technological landscape. By tapping into the demand for superior audio and communication devices, GN Store Nord maintains a robust financial performance while continuously exploring new growth avenues within its core sectors.

GGNDF Intrinsic Value
22.73 USD
Undervaluation 28%
Intrinsic Value
Price $16.41
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett